Literature DB >> 19628633

Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.

Nieves González1, Tomoo Nakagawa, Samuel A Mantey, Veronica Sancho, Hirotsugu Uehara, Tatsuro Katsuno, Robert T Jensen.   

Abstract

The mammalian bombesin (Bn) peptides, neuromedin B (NMB) and gastrin-releasing peptide (GRP), have widespread actions in many tissues, and their effects are mediated by two closely related G-protein-coupled receptors, the NMBR and GRPR. Little is known about the structural determinants of NMBR selectivity for NMB, in contrast to GRP selectivity for the GRPR, which has been extensively studied. To provide insight, chimeric NMBR-GRPR loss-of-affinity and gain-of-affinity mutants were made, as well as NH(2)-terminally truncated NMBR and point mutants using site-directed mutagenesis. Receptors were expressed in Balb-3T3-cells or CHOP cells, and affinities were determined. NMB had 115-fold greater affinity for NMBR than GRPR. Receptor-chimeric studies showed that NMBR selectivity for NMB was primarily determined by differences in the third extracellular (EC3) regions of GRPR-NMBR and adjacent upper-transmembrane-5 (TM5) region. In this region, 24 NMB gain-of-affinity GRPR mutants or NMBR loss-of-affinity point/combination mutants were made. Three gain-of-affinity mutant GRPRs [[A198I] (EC3), [H202Q] (EC3), [S215I] (upper TM5)] had increased NMB affinity (2.4-21-fold), and these results were confirmed with NMBR loss-of-affinity mutants [I199A,Q203H,I215S-NMBR]. The combination mutant [A198I,S215]GRPR had the greatest effect causing a complete NMB gain-of-affinity. The importance of differences at position 199NMBR or 203NMBR was studied by substituting amino acids with various properties. Our results show that NMBR selectivity for NMB is due to differences in the EC3 of NMBR-GRPR and the adjacent upper-TM5 region. Within these regions, isoleucines in NMBR [position 199 (EC3)] (instead of A198GRPR) and in 215NMBR (TM5) (instead of S214GRPR), as well as Q203NMBR (instead of H202GRPR) are responsible for high NMB-affinity/selectivity of NMBR. The effect at position 199 is primarily due to differences in hydrophobicity of the substitution, whereas steric factors and charge of the substitution at position 203 were important determinants of NMB selectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628633      PMCID: PMC2766219          DOI: 10.1124/jpet.109.154245

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  43 in total

1.  The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ.

Authors:  S Greenfeder; B Cheewatrakoolpong; M Billah; R W Egan; E Keene; N J Murgolo; J C Anthes
Journal:  Bioorg Med Chem       Date:  1999-12       Impact factor: 3.641

2.  The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.

Authors:  B Sun; A V Schally; G Halmos
Journal:  Regul Pept       Date:  2000-06-30

Review 3.  Bombesin: potential integrative peptide for feeding and satiety.

Authors:  J G McCoy; D D Avery
Journal:  Peptides       Date:  1990 May-Jun       Impact factor: 3.750

Review 4.  The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer.

Authors:  J A Jensen; R E Carroll; R V Benya
Journal:  Peptides       Date:  2001-04       Impact factor: 3.750

5.  Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells.

Authors:  J F Battey; J M Way; M H Corjay; H Shapira; K Kusano; R Harkins; J M Wu; T Slattery; E Mann; R I Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors.

Authors:  T Von Schrenck; P Heinz-Erian; T Moran; S A Mantey; J D Gardner; R T Jensen
Journal:  Am J Physiol       Date:  1989-04

7.  Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368.

Authors:  K Tokita; S J Hocart; T Katsuno; S A Mantey; D H Coy; R T Jensen
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

Authors:  F Cuttitta; D N Carney; J Mulshine; T W Moody; J Fedorko; A Fischler; J D Minna
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

9.  Residue 219 impacts on the dynamics of the C-terminal region in glutathione transferase A1-1: implications for stability and catalytic and ligandin functions.

Authors:  Salerwe Mosebi; Yasien Sayed; Jonathan Burke; Heini W Dirr
Journal:  Biochemistry       Date:  2003-12-30       Impact factor: 3.162

Review 10.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

View more
  4 in total

1.  Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.

Authors:  Hirotsugu Uehara; Nieves González; Veronica Sancho; Samuel A Mantey; Bernardo Nuche-Berenguer; Tapas Pradhan; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2011-06-28       Impact factor: 3.750

2.  The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members.

Authors:  Hirotsugu Uehara; Simon J Hocart; Nieves González; Samuel A Mantey; Tomoo Nakagawa; Tatsuro Katsuno; David H Coy; Robert T Jensen
Journal:  Biochem Pharmacol       Date:  2012-07-22       Impact factor: 5.858

3.  Role of spinal bombesin-responsive neurons in nonhistaminergic itch.

Authors:  Tasuku Akiyama; Mitsutoshi Tominaga; Kenji Takamori; Mirela Iodi Carstens; E Carstens
Journal:  J Neurophysiol       Date:  2014-08-13       Impact factor: 2.714

4.  Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.

Authors:  Taichi Nakamura; Irene Ramos-Álvarez; Tatiana Iordanskaia; Paola Moreno; Samuel A Mantey; R T Jensen
Journal:  Biochem Pharmacol       Date:  2016-06-23       Impact factor: 5.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.